SCHEMBL10504063

SCHEMBL10504063

CC(C)(CNC(=O)CCCCO[N+](=O)[O-])NCC(O)COc1ccccc1C#N

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 1/20 0.55
▸ ADRA2A P08913 1/20 0.55
▸ ADRA2B P18089 1/20 0.55
▸ MAOA P21397 1/20 0.55
▸ HTR2B P41595 1/20 0.55
▸ CYP2D6 P10635 7/20 0.51
▸ CASR P41180 5/20 0.51
▸ SLC6A2 P23975 3/20 0.51
▸ SLC6A4 P31645 3/20 0.51
▸ SLC6A3 Q01959 3/20 0.51
▸ KCNH2 Q12809 3/20 0.51
▸ ADRB2 P07550 3/20 0.51
▸ ADRB3 P13945 3/20 0.51
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ SLC22A1 O15245 1/20 0.48
▸ ADRB1 P08588 7/20 0.46
▸ KDM4E B2RXH2 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ ALOX15 P16050 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10503937 0.97 HTR1A (0.56) HTR1AADRA2AADRA2BMAOAHTR2B
Fumaric Acid SCHEMBL10505860 0.93 HTR1A (0.51) HTR1AADRA2AADRA2BMAOAHTR2B
SCHEMBL10503983 0.88 HTR1A (0.55) HTR1AADRA2AADRA2BMAOAHTR2B
SCHEMBL10592973 0.88 CASR (0.49) CASRADRB2ADRB3MEN1KMT2A
SCHEMBL10503940 0.85 ADRB2 (0.41) CASRADRB2ADRB3MEN1KMT2A
SCHEMBL10593339 0.85 ADRB2 (0.47) HTR1ACYP2D6CASRSLC6A4ADRB2
SCHEMBL10503702 0.85 CYP2D6 (0.49) HTR1AADRA2AHTR2BCYP2D6CASR
SCHEMBL10592451 0.85 ADRB2 (0.41) CASRADRB2ADRB3MEN1KMT2A
SCHEMBL10594657 0.85 CASR (0.43) HTR1AADRA2AADRA2BMAOAHTR2B
SCHEMBL10592061 0.85 CASR (0.50) CASRADRB2ADRB3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0200915-B1 AMINOPROPANOL DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AND MEDICINES CONTAINING THEM Roche Diagnostics GmbH (DE) 1989-09-27 — — EP disclosed
US-4863949-A CARDIOVASCULAR DISORDER TREATMENT BOEHRINGER MANNHEIM GMBH (DE) 1989-09-05 — — US disclosed
EP-0200915-A1 Aminopropanol derivatives, process for their preparation, their use and medicines containing them Roche Diagnostics GmbH (DE) 1986-11-12 — — EP disclosed
Send feedback